Ubs Asset Management Americas Inc Portfolio Holdings

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

Ubs Asset Management Americas Inc has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $381 Billion distributed in 19362 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $23.5B, Nvidia Corp with a value of $21.9B, Apple Inc. with a value of $21.3B, Amazon Com Inc with a value of $10.8B, and Alphabet Inc. with a value of $6.71B.

Examining the 13F form we can see an increase of $36.8B in the current position value, from $345B to 381B.

Ubs Asset Management Americas Inc is based out at Chicago, IL

Below you can find more details about Ubs Asset Management Americas Inc portfolio as well as his latest detailed transactions.

Portfolio value $381 Billion
Technology: $127 Billion
Financial Services: $46.3 Billion
Healthcare: $45.4 Billion
Consumer Cyclical: $42 Billion
Communication Services: $30.6 Billion
Industrials: $30.4 Billion
Consumer Defensive: $19.7 Billion
Real Estate: $14 Billion
Other: $26.3 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Amc Entmt Hldgs Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 8.78%
$288M
$202,000 0.0% of portfolio
23,356
Q3 2024 Reduced 22.77%
$2.96B
$8.84 Million 0.0% of portfolio
91,647
Q3 2024 Reduced 2.64%
Amentum Holdings Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
$3.16B
$9.86 Million 0.0% of portfolio
118,532
Q3 2024 Reduced 0.18%
$846M
$1.31 Million 0.0% of portfolio
61,172
Q3 2024 Reduced 11.18%
$886M
$2.9 Million 0.0% of portfolio
76,557
Q3 2024 Reduced 10.18%
$7.17B
$7.13 Million 0.0% of portfolio
645,782
Q3 2024 Reduced 42.29%
$1.74B
$11 Million 0.0% of portfolio
411,809
Q3 2024 Added 292.71%
$759M
$1.88 Million 0.0% of portfolio
303,709
Q3 2024 Added 1.32%
$3.35B
$9.22 Million 0.0% of portfolio
411,626
Q3 2024 Added 2.94%
American Healthcare Reit Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 407.79%
$962M
$1.42 Million 0.0% of portfolio
60,332
Q3 2024 New
$1.52B
$3.43 Million 0.0% of portfolio
36,740
Q3 2024 Reduced 4.35%
$296M
$396,000 0.0% of portfolio
9,454
Q3 2024 Reduced 48.26%
$4.95B
$9.26 Million 0.0% of portfolio
148,381
Q3 2024 Added 2.26%
$2.77B
$5.2 Million 0.0% of portfolio
486,769
Q3 2024 Reduced 8.86%
$6.43B
$8.6 Million 0.0% of portfolio
280,890
Q3 2024 Added 5.4%
$1.14B
$3.87 Million 0.0% of portfolio
91,252
Q3 2024 Reduced 4.94%
$1.25B
$1.82 Million 0.0% of portfolio
218,554
Q3 2024 Reduced 17.44%
$2.17B
$3.71 Million 0.0% of portfolio
76,445
Q3 2024 Reduced 10.91%
Amphastar Pharmaceuticals In
-
$0 0.0% of portfolio
-
Q3 2024 New
$701M
$1.2 Million 0.0% of portfolio
134,078
Q3 2024 Reduced 9.02%
Anaptysbio Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 10.87%
$1.62B
$4.02 Million 0.0% of portfolio
80,262
Q3 2024 Reduced 2.78%
$154M
$677,000 0.0% of portfolio
262,529
Q3 2024 Added 46.81%
Anglogold Ashanti PLC
-
$0 0.0% of portfolio
-
Q3 2024 Added 159.04%
$1.01B
$2.03 Million 0.0% of portfolio
33,951
Q3 2024 Reduced 20.99%
Annaly Capital Management In
-
$0 0.0% of portfolio
-
Q3 2024 Added 531.27%
$624M
$849,000 0.0% of portfolio
22,542
Q3 2024 Reduced 7.89%
$7.59B
$13.1 Million 0.0% of portfolio
870,034
Q3 2024 Added 0.92%
$9.93B
$14.9 Million 0.0% of portfolio
521,707
Q3 2024 Reduced 10.22%
$584M
$1.25 Million 0.0% of portfolio
245,270
Q3 2024 Added 4.23%
$1.36B
$7.5 Million 0.0% of portfolio
829,121
Q3 2024 Added 2.61%
$3.58B
$5.51 Million 0.0% of portfolio
191,065
Q3 2024 Reduced 8.22%
$1.89B
$2.83 Million 0.0% of portfolio
40,423
Q3 2024 Reduced 4.97%
Apogee Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 6.28%
$1.3B
$3.5 Million 0.0% of portfolio
380,700
Q3 2024 Reduced 1.91%
Apollo Global Mgmt Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
$1.54B
$2.74 Million 0.0% of portfolio
80,242
Q3 2024 Added 0.62%
$912M
$761,000 0.0% of portfolio
92,316
Q3 2024 New
$10.8B
$16.9 Million 0.0% of portfolio
75,721
Q3 2024 Reduced 9.94%
$1.03B
$962,000 0.0% of portfolio
67,275
Q3 2024 Reduced 5.0%
$121M
$3.22 Million 0.0% of portfolio
1,686,872
Q2 2024 New
$2.53B
$4.54 Million 0.0% of portfolio
291,456
Q3 2024 Added 52.28%
$511M
$753,000 0.0% of portfolio
195,843
Q3 2024 New
Arcadium Lithium PLC
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 14.51%
$2.77B
$12.7 Million 0.0% of portfolio
116,672
Q3 2024 Added 16.01%
$3.24B
$2.46 Million 0.0% of portfolio
17,798
Q3 2024 Reduced 10.28%

Summary

  • Portfolio
  • No. of Stocks 19,362
  • Current Value $381 Billion
  • Prior Value $345 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 127 stocks
  • Additional Purchases 987 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1,606 stocks
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email